1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Oligonucleotides Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 DNA Oligos 1.2.3 RNA Oligos 1.3 Market by Application 1.3.1 Global Oligonucleotides Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Pharmaceutical 1.3.3 Research 1.3.4 Diagnostic 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Oligonucleotides Market Perspective (2016-2027) 2.2 Oligonucleotides Growth Trends by Regions 2.2.1 Oligonucleotides Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Oligonucleotides Historic Market Share by Regions (2016-2021) 2.2.3 Oligonucleotides Forecasted Market Size by Regions (2022-2027) 2.3 Oligonucleotides Industry Dynamic 2.3.1 Oligonucleotides Market Trends 2.3.2 Oligonucleotides Market Drivers 2.3.3 Oligonucleotides Market Challenges 2.3.4 Oligonucleotides Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Oligonucleotides Players by Revenue 3.1.1 Global Top Oligonucleotides Players by Revenue (2016-2021) 3.1.2 Global Oligonucleotides Revenue Market Share by Players (2016-2021) 3.2 Global Oligonucleotides Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Oligonucleotides Revenue 3.4 Global Oligonucleotides Market Concentration Ratio 3.4.1 Global Oligonucleotides Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Oligonucleotides Revenue in 2020 3.5 Oligonucleotides Key Players Head office and Area Served 3.6 Key Players Oligonucleotides Product Solution and Service 3.7 Date of Enter into Oligonucleotides Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Oligonucleotides Breakdown Data by Type 4.1 Global Oligonucleotides Historic Market Size by Type (2016-2021) 4.2 Global Oligonucleotides Forecasted Market Size by Type (2022-2027) 5 Oligonucleotides Breakdown Data by Application 5.1 Global Oligonucleotides Historic Market Size by Application (2016-2021) 5.2 Global Oligonucleotides Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Oligonucleotides Market Size (2016-2027) 6.2 North America Oligonucleotides Market Size by Type 6.2.1 North America Oligonucleotides Market Size by Type (2016-2021) 6.2.2 North America Oligonucleotides Market Size by Type (2022-2027) 6.2.3 North America Oligonucleotides Market Size by Type (2016-2027) 6.3 North America Oligonucleotides Market Size by Application 6.3.1 North America Oligonucleotides Market Size by Application (2016-2021) 6.3.2 North America Oligonucleotides Market Size by Application (2022-2027) 6.3.3 North America Oligonucleotides Market Size by Application (2016-2027) 6.4 North America Oligonucleotides Market Size by Country 6.4.1 North America Oligonucleotides Market Size by Country (2016-2021) 6.4.2 North America Oligonucleotides Market Size by Country (2022-2027) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe Oligonucleotides Market Size (2016-2027) 7.2 Europe Oligonucleotides Market Size by Type 7.2.1 Europe Oligonucleotides Market Size by Type (2016-2021) 7.2.2 Europe Oligonucleotides Market Size by Type (2022-2027) 7.2.3 Europe Oligonucleotides Market Size by Type (2016-2027) 7.3 Europe Oligonucleotides Market Size by Application 7.3.1 Europe Oligonucleotides Market Size by Application (2016-2021) 7.3.2 Europe Oligonucleotides Market Size by Application (2022-2027) 7.3.3 Europe Oligonucleotides Market Size by Application (2016-2027) 7.4 Europe Oligonucleotides Market Size by Country 7.4.1 Europe Oligonucleotides Market Size by Country (2016-2021) 7.4.2 Europe Oligonucleotides Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Oligonucleotides Market Size (2016-2027) 8.2 Asia-Pacific Oligonucleotides Market Size by Type 8.2.1 Asia-Pacific Oligonucleotides Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Oligonucleotides Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Oligonucleotides Market Size by Type (2016-2027) 8.3 Asia-Pacific Oligonucleotides Market Size by Application 8.3.1 Asia-Pacific Oligonucleotides Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Oligonucleotides Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Oligonucleotides Market Size by Application (2016-2027) 8.4 Asia-Pacific Oligonucleotides Market Size by Region 8.4.1 Asia-Pacific Oligonucleotides Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Oligonucleotides Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Oligonucleotides Market Size (2016-2027) 9.2 Latin America Oligonucleotides Market Size by Type 9.2.1 Latin America Oligonucleotides Market Size by Type (2016-2021) 9.2.2 Latin America Oligonucleotides Market Size by Type (2022-2027) 9.2.3 Latin America Oligonucleotides Market Size by Type (2016-2027) 9.3 Latin America Oligonucleotides Market Size by Application 9.3.1 Latin America Oligonucleotides Market Size by Application (2016-2021) 9.3.2 Latin America Oligonucleotides Market Size by Application (2022-2027) 9.3.3 Latin America Oligonucleotides Market Size by Application (2016-2027) 9.4 Latin America Oligonucleotides Market Size by Country 9.4.1 Latin America Oligonucleotides Market Size by Country (2016-2021) 9.4.2 Latin America Oligonucleotides Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Oligonucleotides Market Size (2016-2027) 10.2 Middle East & Africa Oligonucleotides Market Size by Type 10.2.1 Middle East & Africa Oligonucleotides Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Oligonucleotides Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Oligonucleotides Market Size by Type (2016-2027) 10.3 Middle East & Africa Oligonucleotides Market Size by Application 10.3.1 Middle East & Africa Oligonucleotides Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Oligonucleotides Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Oligonucleotides Market Size by Application (2016-2027) 10.4 Middle East & Africa Oligonucleotides Market Size by Country 10.4.1 Middle East & Africa Oligonucleotides Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Oligonucleotides Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Integrated DNA Technologies 11.1.1 Integrated DNA Technologies Company Details 11.1.2 Integrated DNA Technologies Business Overview 11.1.3 Integrated DNA Technologies Oligonucleotides Introduction 11.1.4 Integrated DNA Technologies Revenue in Oligonucleotides Business (2016-2021) 11.1.5 Integrated DNA Technologies Recent Development 11.2 Agilent 11.2.1 Agilent Company Details 11.2.2 Agilent Business Overview 11.2.3 Agilent Oligonucleotides Introduction 11.2.4 Agilent Revenue in Oligonucleotides Business (2016-2021) 11.2.5 Agilent Recent Development 11.3 Sigma-aldrich 11.3.1 Sigma-aldrich Company Details 11.3.2 Sigma-aldrich Business Overview 11.3.3 Sigma-aldrich Oligonucleotides Introduction 11.3.4 Sigma-aldrich Revenue in Oligonucleotides Business (2016-2021) 11.3.5 Sigma-aldrich Recent Development 11.4 Eurofins Genomics 11.4.1 Eurofins Genomics Company Details 11.4.2 Eurofins Genomics Business Overview 11.4.3 Eurofins Genomics Oligonucleotides Introduction 11.4.4 Eurofins Genomics Revenue in Oligonucleotides Business (2016-2021) 11.4.5 Eurofins Genomics Recent Development 11.5 L.G.C Biosearch Technologies 11.5.1 L.G.C Biosearch Technologies Company Details 11.5.2 L.G.C Biosearch Technologies Business Overview 11.5.3 L.G.C Biosearch Technologies Oligonucleotides Introduction 11.5.4 L.G.C Biosearch Technologies Revenue in Oligonucleotides Business (2016-2021) 11.5.5 L.G.C Biosearch Technologies Recent Development 11.6 Eurogentec S.A 11.6.1 Eurogentec S.A Company Details 11.6.2 Eurogentec S.A Business Overview 11.6.3 Eurogentec S.A Oligonucleotides Introduction 11.6.4 Eurogentec S.A Revenue in Oligonucleotides Business (2016-2021) 11.6.5 Eurogentec S.A Recent Development 11.7 Nitto Denko Avecia Inc 11.7.1 Nitto Denko Avecia Inc Company Details 11.7.2 Nitto Denko Avecia Inc Business Overview 11.7.3 Nitto Denko Avecia Inc Oligonucleotides Introduction 11.7.4 Nitto Denko Avecia Inc Revenue in Oligonucleotides Business (2016-2021) 11.7.5 Nitto Denko Avecia Inc Recent Development 11.8 GenScript 11.8.1 GenScript Company Details 11.8.2 GenScript Business Overview 11.8.3 GenScript Oligonucleotides Introduction 11.8.4 GenScript Revenue in Oligonucleotides Business (2016-2021) 11.8.5 GenScript Recent Development 11.9 BBI Life Sciences 11.9.1 BBI Life Sciences Company Details 11.9.2 BBI Life Sciences Business Overview 11.9.3 BBI Life Sciences Oligonucleotides Introduction 11.9.4 BBI Life Sciences Revenue in Oligonucleotides Business (2016-2021) 11.9.5 BBI Life Sciences Recent Development 11.10 GeneDesign 11.10.1 GeneDesign Company Details 11.10.2 GeneDesign Business Overview 11.10.3 GeneDesign Oligonucleotides Introduction 11.10.4 GeneDesign Revenue in Oligonucleotides Business (2016-2021) 11.10.5 GeneDesign Recent Development 11.11 TriLink BioTechnologies 11.11.1 TriLink BioTechnologies Company Details 11.11.2 TriLink BioTechnologies Business Overview 11.11.3 TriLink BioTechnologies Oligonucleotides Introduction 11.11.4 TriLink BioTechnologies Revenue in Oligonucleotides Business (2016-2021) 11.11.5 TriLink BioTechnologies Recent Development 11.12 SGS DNA 11.12.1 SGS DNA Company Details 11.12.2 SGS DNA Business Overview 11.12.3 SGS DNA Oligonucleotides Introduction 11.12.4 SGS DNA Revenue in Oligonucleotides Business (2016-2021) 11.12.5 SGS DNA Recent Development 11.13 LC Sciences 11.13.1 LC Sciences Company Details 11.13.2 LC Sciences Business Overview 11.13.3 LC Sciences Oligonucleotides Introduction 11.13.4 LC Sciences Revenue in Oligonucleotides Business (2016-2021) 11.13.5 LC Sciences Recent Development 11.14 Twist Bioscience 11.14.1 Twist Bioscience Company Details 11.14.2 Twist Bioscience Business Overview 11.14.3 Twist Bioscience Oligonucleotides Introduction 11.14.4 Twist Bioscience Revenue in Oligonucleotides Business (2016-2021) 11.14.5 Twist Bioscience Recent Development 11.15 Creative Biogene 11.15.1 Creative Biogene Company Details 11.15.2 Creative Biogene Business Overview 11.15.3 Creative Biogene Oligonucleotides Introduction 11.15.4 Creative Biogene Revenue in Oligonucleotides Business (2016-2021) 11.15.5 Creative Biogene Recent Development 11.16 General Biosystems 11.16.1 General Biosystems Company Details 11.16.2 General Biosystems Business Overview 11.16.3 General Biosystems Oligonucleotides Introduction 11.16.4 General Biosystems Revenue in Oligonucleotides Business (2016-2021) 11.16.5 General Biosystems Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Oligonucleotides Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of DNA Oligos Table 3. Key Players of RNA Oligos Table 4. Global Oligonucleotides Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 5. Global Oligonucleotides Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 6. Global Oligonucleotides Market Size by Regions (2016-2021) & (US$ Million) Table 7. Global Oligonucleotides Market Share by Regions (2016-2021) Table 8. Global Oligonucleotides Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 9. Global Oligonucleotides Market Share by Regions (2022-2027) Table 10. Oligonucleotides Market Trends Table 11. Oligonucleotides Market Drivers Table 12. Oligonucleotides Market Challenges Table 13. Oligonucleotides Market Restraints Table 14. Global Oligonucleotides Revenue by Players (2016-2021) & (US$ Million) Table 15. Global Oligonucleotides Market Share by Players (2016-2021) Table 16. Global Top Oligonucleotides Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Oligonucleotides as of 2020) Table 17. Ranking of Global Top Oligonucleotides Companies by Revenue (US$ Million) in 2020 Table 18. Global 5 Largest Players Market Share by Oligonucleotides Revenue (CR5 and HHI) & (2016-2021) Table 19. Key Players Headquarters and Area Served Table 20. Key Players Oligonucleotides Product Solution and Service Table 21. Date of Enter into Oligonucleotides Market Table 22. Mergers & Acquisitions, Expansion Plans Table 23. Global Oligonucleotides Market Size by Type (2016-2021) (US$ Million) Table 24. Global Oligonucleotides Revenue Market Share by Type (2016-2021) Table 25. Global Oligonucleotides Forecasted Market Size by Type (2022-2027) (US$ Million) Table 26. Global Oligonucleotides Revenue Market Share by Type (2022-2027) & (US$ Million) Table 27. Global Oligonucleotides Market Size Share by Application (2016-2021) & (US$ Million) Table 28. Global Oligonucleotides Revenue Market Share by Application (2016-2021) Table 29. Global Oligonucleotides Forecasted Market Size by Application (2022-2027) (US$ Million) Table 30. Global Oligonucleotides Revenue Market Share by Application (2022-2027) & (US$ Million) Table 31. North America Oligonucleotides Market Size by Type (2016-2021) (US$ Million) Table 32. North America Oligonucleotides Market Size by Type (2022-2027) & (US$ Million) Table 33. North America Oligonucleotides Market Size by Application (2016-2021) (US$ Million) Table 34. North America Oligonucleotides Market Size by Application (2022-2027) & (US$ Million) Table 35. North America Oligonucleotides Market Size by Country (2016-2021) & (US$ Million) Table 36. North America Oligonucleotides Market Size by Country (2022-2027) & (US$ Million) Table 37. Europe Oligonucleotides Market Size by Type (2016-2021) (US$ Million) Table 38. Europe Oligonucleotides Market Size by Type (2022-2027) & (US$ Million) Table 39. Europe Oligonucleotides Market Size by Application (2016-2021) (US$ Million) Table 40. Europe Oligonucleotides Market Size by Application (2022-2027) & (US$ Million) Table 41. Europe Oligonucleotides Market Size by Country (2016-2021) & (US$ Million) Table 42. Europe Oligonucleotides Market Size by Country (2022-2027) & (US$ Million) Table 43. Asia-Pacific Oligonucleotides Market Size by Type (2016-2021) (US$ Million) Table 44. Asia-Pacific Oligonucleotides Market Size by Type (2022-2027) & (US$ Million) Table 45. Asia-Pacific Oligonucleotides Market Size by Application (2016-2021) (US$ Million) Table 46. Asia-Pacific Oligonucleotides Market Size by Application (2022-2027) & (US$ Million) Table 47. Asia-Pacific Oligonucleotides Market Size by Region (2016-2021) & (US$ Million) Table 48. Asia-Pacific Oligonucleotides Market Size by Region (2022-2027) & (US$ Million) Table 49. Latin America Oligonucleotides Market Size by Type (2016-2021) (US$ Million) Table 50. Latin America Oligonucleotides Market Size by Type (2022-2027) & (US$ Million) Table 51. Latin America Oligonucleotides Market Size by Application (2016-2021) (US$ Million) Table 52. Latin America Oligonucleotides Market Size by Application (2022-2027) & (US$ Million) Table 53. Latin America Oligonucleotides Market Size by Country (2016-2021) & (US$ Million) Table 54. Latin America Oligonucleotides Market Size by Country (2022-2027) & (US$ Million) Table 55. Middle East & Africa Oligonucleotides Market Size by Type (2016-2021) (US$ Million) Table 56. Middle East & Africa Oligonucleotides Market Size by Type (2022-2027) & (US$ Million) Table 57. Middle East & Africa Oligonucleotides Market Size by Application (2016-2021) (US$ Million) Table 58. Middle East & Africa Oligonucleotides Market Size by Application (2022-2027) & (US$ Million) Table 59. Middle East & Africa Oligonucleotides Market Size by Country (2016-2021) & (US$ Million) Table 60. Middle East & Africa Oligonucleotides Market Size by Country (2022-2027) & (US$ Million) Table 61. Integrated DNA Technologies Company Details Table 62. Integrated DNA Technologies Business Overview Table 63. Integrated DNA Technologies Oligonucleotides Product Table 64. Integrated DNA Technologies Revenue in Oligonucleotides Business (2016-2021) & (US$ Million) Table 65. Integrated DNA Technologies Recent Development Table 66. Agilent Company Details Table 67. Agilent Business Overview Table 68. Agilent Oligonucleotides Product Table 69. Agilent Revenue in Oligonucleotides Business (2016-2021) & (US$ Million) Table 70. Agilent Recent Development Table 71. Sigma-aldrich Company Details Table 72. Sigma-aldrich Business Overview Table 73. Sigma-aldrich Oligonucleotides Product Table 74. Sigma-aldrich Revenue in Oligonucleotides Business (2016-2021) & (US$ Million) Table 75. Sigma-aldrich Recent Development Table 76. Eurofins Genomics Company Details Table 77. Eurofins Genomics Business Overview Table 78. Eurofins Genomics Oligonucleotides Product Table 79. Eurofins Genomics Revenue in Oligonucleotides Business (2016-2021) & (US$ Million) Table 80. Eurofins Genomics Recent Development Table 81. L.G.C Biosearch Technologies Company Details Table 82. L.G.C Biosearch Technologies Business Overview Table 83. L.G.C Biosearch Technologies Oligonucleotides Product Table 84. L.G.C Biosearch Technologies Revenue in Oligonucleotides Business (2016-2021) & (US$ Million) Table 85. L.G.C Biosearch Technologies Recent Development Table 86. Eurogentec S.A Company Details Table 87. Eurogentec S.A Business Overview Table 88. Eurogentec S.A Oligonucleotides Product Table 89. Eurogentec S.A Revenue in Oligonucleotides Business (2016-2021) & (US$ Million) Table 90. Eurogentec S.A Recent Development Table 91. Nitto Denko Avecia Inc Company Details Table 92. Nitto Denko Avecia Inc Business Overview Table 93. Nitto Denko Avecia Inc Oligonucleotides Product Table 94. Nitto Denko Avecia Inc Revenue in Oligonucleotides Business (2016-2021) & (US$ Million) Table 95. Nitto Denko Avecia Inc Recent Development Table 96. GenScript Company Details Table 97. GenScript Business Overview Table 98. GenScript Revenue in Oligonucleotides Business (2016-2021) & (US$ Million) Table 99. GenScript Recent Development Table 100. BBI Life Sciences Company Details Table 101. BBI Life Sciences Business Overview Table 102. BBI Life Sciences Oligonucleotides Product Table 103. BBI Life Sciences Revenue in Oligonucleotides Business (2016-2021) & (US$ Million) Table 104. BBI Life Sciences Recent Development Table 105. GeneDesign Company Details Table 106. GeneDesign Business Overview Table 107. GeneDesign Oligonucleotides Product Table 108. GeneDesign Revenue in Oligonucleotides Business (2016-2021) & (US$ Million) Table 109. GeneDesign Recent Development Table 110. TriLink BioTechnologies Company Details Table 111. TriLink BioTechnologies Business Overview Table 112. TriLink BioTechnologies Oligonucleotides Product Table 113. TriLink BioTechnologies Revenue in Oligonucleotides Business (2016-2021) & (US$ Million) Table 114. TriLink BioTechnologies Recent Development Table 115. SGS DNA Company Details Table 116. SGS DNA Business Overview Table 117. SGS DNA Oligonucleotides Product Table 118. SGS DNA Revenue in Oligonucleotides Business (2016-2021) & (US$ Million) Table 119. SGS DNA Recent Development Table 120. LC Sciences Company Details Table 121. LC Sciences Business Overview Table 122. LC Sciences Oligonucleotides Product Table 123. LC Sciences Revenue in Oligonucleotides Business (2016-2021) & (US$ Million) Table 124. LC Sciences Recent Development Table 125. Twist Bioscience Company Details Table 126. Twist Bioscience Business Overview Table 127. Twist Bioscience Oligonucleotides Product Table 128. Twist Bioscience Revenue in Oligonucleotides Business (2016-2021) & (US$ Million) Table 129. Twist Bioscience Recent Development Table 130. Creative Biogene Company Details Table 131. Creative Biogene Business Overview Table 132. Creative Biogene Oligonucleotides Product Table 133. Creative Biogene Revenue in Oligonucleotides Business (2016-2021) & (US$ Million) Table 134. Creative Biogene Recent Development Table 135. General Biosystems Company Details Table 136. General Biosystems Business Overview Table 137. General Biosystems Oligonucleotides Product Table 138. General Biosystems Revenue in Oligonucleotides Business (2016-2021) & (US$ Million) Table 139. General Biosystems Recent Development Table 140. Research Programs/Design for This Report Table 141. Key Data Information from Secondary Sources Table 142. Key Data Information from Primary Sources List of Figures Figure 1. Global Oligonucleotides Market Share by Type: 2020 VS 2027 Figure 2. DNA Oligos Features Figure 3. RNA Oligos Features Figure 4. Global Oligonucleotides Market Share by Application: 2020 VS 2027 Figure 5. Pharmaceutical Case Studies Figure 6. Research Case Studies Figure 7. Diagnostic Case Studies Figure 8. Oligonucleotides Report Years Considered Figure 9. Global Oligonucleotides Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 10. Global Oligonucleotides Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 11. Global Oligonucleotides Market Share by Regions: 2020 VS 2027 Figure 12. Global Oligonucleotides Market Share by Regions (2022-2027) Figure 13. Global Oligonucleotides Market Share by Players in 2020 Figure 14. Global Top Oligonucleotides Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Oligonucleotides as of 2020 Figure 15. The Top 10 and 5 Players Market Share by Oligonucleotides Revenue in 2020 Figure 16. Global Oligonucleotides Revenue Market Share by Type (2016-2021) Figure 17. Global Oligonucleotides Revenue Market Share by Type (2022-2027) Figure 18. North America Oligonucleotides Market Size YoY Growth (2016-2027) & (US$ Million) Figure 19. North America Oligonucleotides Market Share by Type (2016-2027) Figure 20. North America Oligonucleotides Market Share by Application (2016-2027) Figure 21. North America Oligonucleotides Market Share by Country (2016-2027) Figure 22. United States Oligonucleotides Market Size YoY Growth (2016-2027) & (US$ Million) Figure 23. Canada Oligonucleotides Market Size YoY Growth (2016-2027) & (US$ Million) Figure 24. Europe Oligonucleotides Market Size YoY Growth (2016-2027) & (US$ Million) Figure 25. Europe Oligonucleotides Market Share by Type (2016-2027) Figure 26. Europe Oligonucleotides Market Share by Application (2016-2027) Figure 27. Europe Oligonucleotides Market Share by Country (2016-2027) Figure 28. Germany Oligonucleotides Market Size YoY Growth (2016-2027) & (US$ Million) Figure 29. France Oligonucleotides Market Size YoY Growth (2016-2027) & (US$ Million) Figure 30. U.K. Oligonucleotides Market Size YoY Growth (2016-2027) & (US$ Million) Figure 31. Italy Oligonucleotides Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. Russia Oligonucleotides Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. Nordic Oligonucleotides Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. Asia-Pacific Oligonucleotides Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. Asia-Pacific Oligonucleotides Market Share by Type (2016-2027) Figure 36. Asia-Pacific Oligonucleotides Market Share by Application (2016-2027) Figure 37. Asia-Pacific Oligonucleotides Market Share by Region (2016-2027) Figure 38. China Oligonucleotides Market Size YoY Growth (2016-2027) & (US$ Million) Figure 39. Japan Oligonucleotides Market Size YoY Growth (2016-2027) & (US$ Million) Figure 40. South Korea Oligonucleotides Market Size YoY Growth (2016-2027) & (US$ Million) Figure 41. Southeast Asia Oligonucleotides Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. India Oligonucleotides Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. Australia Oligonucleotides Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. Latin America Oligonucleotides Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. Latin America Oligonucleotides Market Share by Type (2016-2027) Figure 46. Latin America Oligonucleotides Market Share by Application (2016-2027) Figure 47. Latin America Oligonucleotides Market Share by Country (2016-2027) Figure 48. Mexico Oligonucleotides Market Size YoY Growth (2016-2027) & (US$ Million) Figure 49. Brazil Oligonucleotides Market Size YoY Growth (2016-2027) & (US$ Million) Figure 50. Middle East & Africa Oligonucleotides Market Size YoY Growth (2016-2027) & (US$ Million) Figure 51. Middle East & Africa Oligonucleotides Market Share by Type (2016-2027) Figure 52. Middle East & Africa Oligonucleotides Market Share by Application (2016-2027) Figure 53. Middle East & Africa Oligonucleotides Market Share by Country (2016-2027) Figure 54. Turkey Oligonucleotides Market Size YoY Growth (2016-2027) & (US$ Million) Figure 55. Saudi Arabia Oligonucleotides Market Size YoY Growth (2016-2027) & (US$ Million) Figure 56. UAE Oligonucleotides Market Size YoY Growth (2016-2027) & (US$ Million) Figure 57. Integrated DNA Technologies Revenue Growth Rate in Oligonucleotides Business (2016-2021) Figure 58. Agilent Revenue Growth Rate in Oligonucleotides Business (2016-2021) Figure 59. Sigma-aldrich Revenue Growth Rate in Oligonucleotides Business (2016-2021) Figure 60. Eurofins Genomics Revenue Growth Rate in Oligonucleotides Business (2016-2021) Figure 61. L.G.C Biosearch Technologies Revenue Growth Rate in Oligonucleotides Business (2016-2021) Figure 62. Eurogentec S.A Revenue Growth Rate in Oligonucleotides Business (2016-2021) Figure 63. Nitto Denko Avecia Inc Revenue Growth Rate in Oligonucleotides Business (2016-2021) Figure 64. GenScript Revenue Growth Rate in Oligonucleotides Business (2016-2021) Figure 65. BBI Life Sciences Revenue Growth Rate in Oligonucleotides Business (2016-2021) Figure 66. GeneDesign Revenue Growth Rate in Oligonucleotides Business (2016-2021) Figure 67. TriLink BioTechnologies Revenue Growth Rate in Oligonucleotides Business (2016-2021) Figure 68. SGS DNA Revenue Growth Rate in Oligonucleotides Business (2016-2021) Figure 69. LC Sciences Revenue Growth Rate in Oligonucleotides Business (2016-2021) Figure 70. Twist Bioscience Revenue Growth Rate in Oligonucleotides Business (2016-2021) Figure 71. Creative Biogene Revenue Growth Rate in Oligonucleotides Business (2016-2021) Figure 72. General Biosystems Revenue Growth Rate in Oligonucleotides Business (2016-2021) Figure 73. Bottom-up and Top-down Approaches for This Report Figure 74. Data Triangulation Figure 75. Key Executives Interviewed

Integrated DNA Technologies Agilent Sigma-aldrich Eurofins Genomics L.G.C Biosearch Technologies Eurogentec S.A Nitto Denko Avecia Inc GenScript BBI Life Sciences GeneDesign TriLink BioTechnologies SGS DNA LC Sciences Twist Bioscience Creative Biogene General Biosystems